2023
Unlocking the Proteome - The NULISA™ Platform
Entrant
Halteres Associates
Category
Video, Commercial & Film - Medical
Client's Name
Alamar Biosciences
Country / Region
United States
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant
Love Communications
Category
Integrated Marketing - Product Branding
Country / Region
United States
Entrant
MI Health Agency
Category
Video, Commercial & Film - Public Service & Activism
Country / Region
Ukraine
Entrant
Halteres Associates
Category
Social Media - Public Health
Country / Region
United States
Entrant
AML Communications Limited
Category
Video, Commercial & Film - TV Commercial
Country / Region
United Kingdom